2020 Journal Article High-plex and high-throughput digital spatial profiling of non-small-cell lung cancer (NSCLC)Monkman, James, Taheri, Touraj, Warkiani, Majid Ebrahimi, O’Leary, Connor, Ladwa, Rahul, Richard, Derek, O’ Byrne, Ken and Kulasinghe, Arutha (2020). High-plex and high-throughput digital spatial profiling of non-small-cell lung cancer (NSCLC). Cancers, 12 (12) 3551, 1-16. doi: 10.3390/cancers12123551 |
2020 Journal Article Transformation or progression from adenocarcinoma to small cell lung cancer detected by serially tracking mutations in the bloodKulasinghe, Arutha, Monkman, James, Nalder, Mark, O’Leary, Connor, Ladwa, Rahul and O’Byrne, Ken (2020). Transformation or progression from adenocarcinoma to small cell lung cancer detected by serially tracking mutations in the blood. Reports, 3 (4) 33, 33. doi: 10.3390/reports3040033 |
2020 Conference Publication Highly multiplexed digital spatial profiling of the tumor microenvironment of non-small-cell lung cancer (NSCLC)Kulasinghe, Arutha, O’Leary, Connor, Ladwa, Rahul, Warkiani, Majid and O’byrne, Kenneth (2020). Highly multiplexed digital spatial profiling of the tumor microenvironment of non-small-cell lung cancer (NSCLC). 35th Anniversary Annual Meeting (SITC 2020), Virtual, 9-14 November 2020. London, United Kingdom: BMJ Group. doi: 10.1136/jitc-2020-sitc2020.0043 |
2020 Journal Article Epidermal growth factor receptor (EGFR)-mutated non-small-cell lung cancer (NSCLC)O’Leary, Connor, Gasper, Harry, Sahin, Katherine B., Tang, Ming, Kulasinghe, Arutha, Adams, Mark N., Richard, Derek J. and O’Byrne, Ken J. (2020). Epidermal growth factor receptor (EGFR)-mutated non-small-cell lung cancer (NSCLC). Pharmaceuticals, 13 (10) 273, 1-16. doi: 10.3390/ph13100273 |
2020 Journal Article Ex vivo culture of circulating tumour cells derived from non-small cell lung cancerKapeleris, Joanna, Kulasinghe, Arutha, Warkiani, Majid Ebrahimi, Oleary, Connor, Vela, Ian, Leo, Paul, Sternes, Peter, O'Byrne, Kenneth and Punyadeera, Chamindie (2020). Ex vivo culture of circulating tumour cells derived from non-small cell lung cancer. Translational Lung Cancer Research, 9 (5), 1795-1809. doi: 10.21037/tlcr-20-521 |
2020 Journal Article Computed tomography texture analysis of response to second-line nivolumab in metastatic non-small cell lung cancerLadwa, Rahul, Roberts, Kate E., O'Leary, Connor, Maggacis, Nicole, O'Byrne, Kenneth J. and Miles, Kenneth (2020). Computed tomography texture analysis of response to second-line nivolumab in metastatic non-small cell lung cancer. Lung Cancer Management, 9 (3) LMT38, 1-8. doi: 10.2217/lmt-2020-0002 |
2020 Journal Article Unilateral autoimmune inner ear disease in a patient with lung cancer treated with nivolumabRajapakse, Aleksandra, O’Leary, Connor, Gundelach, Raefe, Deva, Rajeev and O’Byrne, Ken (2020). Unilateral autoimmune inner ear disease in a patient with lung cancer treated with nivolumab. Oxford Medical Case Reports, 2020 (9) omaa077, 326-9. doi: 10.1093/omcr/omaa077 |
2020 Journal Article Challenges associated with systemic therapy for older patients with inoperable non-small cell lung cancerO'Leary, Connor, McSorley, Lynda, Hennessy, Bryan, Grogan, Liam, Breathnach, Oscar and Morris, Patrick (2020). Challenges associated with systemic therapy for older patients with inoperable non-small cell lung cancer. Expert Opinion on Pharmacotherapy, 21 (17), 2185-2194. doi: 10.1080/14656566.2020.1801639 |
2020 Conference Publication Limited benefit of adjuvant chemotherapy in resected Epidermal Growth Factor Receptor (EGFR) positive non-small cell lung cancer (NSCLC)O'Leary, Connor, Fletcher, James, Yuile, Alexander, Xu, Wen, Ladwa, Rahul, McGrath, Margaret, Pavlakis, Nick, Hughes, Brett, McCaffery, Elizabeth and O'Byrne, Kenneth (2020). Limited benefit of adjuvant chemotherapy in resected Epidermal Growth Factor Receptor (EGFR) positive non-small cell lung cancer (NSCLC). Medical Oncology Group of Australia Annual Scientific Meeting, Virtual, Australia, 14-21 August 2020. Chichester, West Sussex, United Kingdom: Wiley-Blackwell. |
2020 Journal Article The therapeutic potential of DNA damage repair pathways and genomic stability in lung cancerBurgess, Joshua T., Rose, Maddison, Boucher, Didier, Plowman, Jennifer, Molloy, Christopher, Fisher, Mark, O'Leary, Connor, Richard, Derek J., O'Byrne, Kenneth J. and Bolderson, Emma (2020). The therapeutic potential of DNA damage repair pathways and genomic stability in lung cancer. Frontiers in Oncology, 10 1256. doi: 10.3389/fonc.2020.01256 |
2020 Conference Publication Culture of circulating tumour cells derived from non-small cell lung cancerO'Byrne, Kenneth John, Kapeleris, Joanna, Kulasinghe, Arutha, Warkiani, Majid E., O'Leary, Connor Gerard, Ladwa, Rahul, Vela, Ian, Leo, Paul, Sternes, Peter and Punyadeera, Chamindie (2020). Culture of circulating tumour cells derived from non-small cell lung cancer. 2020 ASCO Annual Meeting, Online, 30 May 2020. Alexandria, VA USA: American Society of Clinical Oncology. doi: 10.1200/jco.2020.38.15_suppl.e21692 |
2020 Journal Article Professional burnout, work patterns and career satisfaction in medical oncologists in IrelandCorrigan, Lynda, O'Leary, Connor, Kroes, Jeska, Farooq, Abdul Rehman, Horgan, Anne, Calvert, Paula and O'Connor, Miriam (2020). Professional burnout, work patterns and career satisfaction in medical oncologists in Ireland. Irish Journal of Medical Science, 189 (2), 711-718. doi: 10.1007/s11845-019-02088-3 |
2019 Journal Article Targeting BRAF mutations in non-small cell lung cancerO'Leary, Connor Gerard, Andelkovic, Vladamir, Ladwa, Rahul, Pavlakis, Nick, Zhou, Caicun, Hirsch, Fred, Richard, Derek and O'Byrne, Kenneth (2019). Targeting BRAF mutations in non-small cell lung cancer. Translational Lung Cancer Research, 8 (6), 1119-1124. doi: 10.21037/tlcr.2019.10.22 |
2019 Journal Article Rearranged during transfection fusions in non-small cell lung cancerO’Leary, Connor, Xu, Wen, Pavlakis, Nick, Richard, Derek and O’Byrne, Ken (2019). Rearranged during transfection fusions in non-small cell lung cancer. Cancers, 11 (5) 620, 620. doi: 10.3390/cancers11050620 |
2018 Conference Publication The impact of the 21 gene recurrence score (RS) on chemotherapy (CHemoRx) prescribing in hormone receptor (HR) positive, lymph node positive (LN+) early-stage breast cancer (BC) in Ireland: A national, multi-centre, prospective study (CTRIAL-IE 15-34)Hassan, A., Keegan, N., O’Leary, C., McSorley, L., Mahgoub, T., O’Reilly, S., Walshe, J., Kennedy, M.J., Coate, L., O’Connor, M., Keane, M., Kelly, C.M., Milewski, M., Molloy, S., Eagan, K., Murphy, V., Breathnach, O.S., Grogan, L., Hennessy, B. and Morris, P.G. (2018). The impact of the 21 gene recurrence score (RS) on chemotherapy (CHemoRx) prescribing in hormone receptor (HR) positive, lymph node positive (LN+) early-stage breast cancer (BC) in Ireland: A national, multi-centre, prospective study (CTRIAL-IE 15-34). 43rd ESMO Congress (ESMO 2018), Munich, Germany, 19–23 October 2018. Amsterdam, Netherlands: Elsevier. doi: 10.1093/annonc/mdy270.203 |
2018 Journal Article Epidermal growth factor receptor mutated oligometastatic adeno-squamous lung cancer transformation to small cell lung cancerO'Leary, Connor G., Corrigan, Lynda, Martin, Petra, Horgan, Anne, O'Connor, Miriam and Calvert, Paula (2018). Epidermal growth factor receptor mutated oligometastatic adeno-squamous lung cancer transformation to small cell lung cancer. Oxford Medical Case Reports, 2018 (10) omy078, 353-356. doi: 10.1093/omcr/omy078 |
2018 Conference Publication Rectal cancer in the elderly: A review of treatment variances between younger and older patientsCorrigan, Lynda, O'Leary, Connor Gerard, Kroes, Jeska, Calvert, Paula, O'Connor, Miriam, Martin, Petra, Cooke, Fiachra and Horgan, Anne M. (2018). Rectal cancer in the elderly: A review of treatment variances between younger and older patients. Cancers of the Colon, Rectum, and Anus, Unknown, Unknown. American Society of Clinical Oncology (ASCO). doi: 10.1200/jco.2018.36.4_suppl.839 |
2017 Conference Publication Reduced-intensity bevacizumab in progressive glioblastoma multiforme (GBM) is associated with similar overall survival versus standard-dosingGleeson, J. P., Keegan, N., Harrold, E., Kamel, D., Karadawi, N., Mammadov, E., Kelly, D., O'Leary, C., O'Halloran, P., Egan, K., Molloy, S., Mac Nally, S., Hennessy, B. T., Breathnach, O. S., Grogan, W. and Morris, P. G. (2017). Reduced-intensity bevacizumab in progressive glioblastoma multiforme (GBM) is associated with similar overall survival versus standard-dosing. 42nd European Society for Medical Oncology Congress (ESMO), Madrid, Spain, 8-12 September 2017. Amsterdam, Netherlands: Elsevier. doi: 10.1093/annonc/mdx366.023 |
2017 Conference Publication Oncotype DX score, menopausal status and body mass indexPicardo, S., Sui, J., Greally, M., Woulfe, B., Prior, L., Corrigan, L., O'Leary, C., Mullally, W., Walshe, J., McCaffrey, J., O'Connor, M., O'Mahony, D., Coate, L., Gupta, R. and O'Reilly, S. (2017). Oncotype DX score, menopausal status and body mass index. 42nd ESMO Congress (ESMO 2017), Madrid, Spain, 8-12 September 2017. Amsterdam, Netherlands: Elsevier. doi: 10.1093/annonc/mdx362.043 |
2017 Journal Article Anti-Ri antibody associated small cell lung carcinomaO'Leary, C. G., Battley, J. E. and O'Reilly, S. (2017). Anti-Ri antibody associated small cell lung carcinoma. Irish Journal of Medical Science, 186 (2), 265-267. doi: 10.1007/s11845-016-1402-1 |